The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

After the U.S. Food and Drug Administration recalled thousands of bottles of antidepressants it said contained high levels of a cancer-causing chemical, the federal agency has now upgraded the level ...

The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...

The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially cancer-causing chemicals in the medication.

Thousands of bottles of a popular antidepressant have been pulled from the market after tests detected ... damage discovered ...

Thousands of bottles of the antidepressant duloxetine ... She previously worked at Bloomberg News and has written for national news outlets including USA Today and Consumer Reports.

Feeling depressed when the stock market is down? You have plenty of company. According to a recent study, when stock prices fall, the number of antidepressant prescriptions rises. The researchers ...

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...

Luye Pharma Group (HK:2186) has released an update. Luye Pharma Group has received approval from China’s National Medical Products ...

Depression occurs in up to two-thirds of patients with stroke, and placebo-controlled trials have shown improvement in post-stroke depressive symptoms with antidepressant drug treatment.

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.